Slideshow

Pain Management: 3 New Things

Author(s):

What’s new: cannabinoids, mindfulness, and the depression-arthritis connection.

References1. De Vita MJ, Moskal D, Maisto SA, et al. Association of cannabinoid administration with experimental pain in healthy adults: a systematic review and meta-analysis. JAMA Psychiatry. Published online September 19, 2018. doi:10.1001/jamapsychiatry.2018.2503.2. Zeidan F, Salomons T, Farris SR, et al. Neural mechanisms supporting the relationship between dispositional mindfulness and pain. Pain. 2018 Jul 12. doi: 10.1097/j.pain.0000000000001344.3. Brooks JM, Titus AJ, Polenick CA, et al. Prevalence rates of arthritis among US older adults with varying degrees of depression: findings from the 2011 to 2014 National Health and Nutrition Examination Survey. Int J Geriatr Psychiatry. 2018 Sep 19. doi: 10.1002/gps.4971.

Related Videos
The Evolving Use of Biologics for PsA Care, with Philip Mease, MD
Achieving Complete Renal Response and Reducing Corticosteroid Use in Lupus Nephritis Treatment With Obinutuzmab, with Richard Furie, MD
Identifying B-cell Depleting Agents for Lupus Nephritis, with Richard Furie, MD
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
© 2025 MJH Life Sciences

All rights reserved.